Transforming Healthcare Through

Point-of-Care Molecular Diagnostics

Enhance community health outcomes with timely, high-quality diagnostic solutions tailored to your patients’ preferred care setting.

Explore

The way people consume healthcare is changing

binx health is dedicated to expanding convenient and equitable access to healthcare. Our point-of-care diagnostic solutions enable our partners to break through traditional barriers to care, expand their reach, and provide exceptional patient experiences.

We've got you covered with our point-of-care solutions

binx io

FDA-Cleared, CLIA-Waived

binx io is a molecular point-of-care testing platform designed to enable single-visit diagnosis and treatment of chlamydia and gonorrhea infections.

30-minute time to results

Established reimbursement

Male and female patients

Learn more

In the news

Our programs in action

View all news

January 23, 2025

binx health and Mass General Hospital Study Shows Significant Positive Impact on Antibiotic Stewardship in Sexual Health

July 2, 2024

Binx Health Continues National Expansion of Onsite Test and Treat on Heels of Alarming WHO Report

April 1, 2024

65-million-to-fuel-National-Growth

February 12, 2024

binx health Enters into National Distribution Agreement with Cardinal Health to Increase Access to the CLIA-waived, FDA-cleared binx io

December 4, 2023

imaware acquires binx health’s consumer testing business, becoming a leader in STI health screening

November 27, 2023

binx health Expands Nationwide Distribution of the binx io Molecular Point-of-Care Platform

April 24, 2023

binx health and Mark Cuban Cost Plus Drug Company Team Up to Make Healthcare More Accessible and Affordable

April 17, 2023

binx health Further Expands Commercial Team in Support of Point-of-Care National Rollout

March 7, 2023

binx health and the Elton John AIDS Foundation Aim to Break Down Barriers to PrEP and STI Screening Through Convenient binx everywhere At-home Solutions

March 1, 2023

binx health and Birmingham AIDS Outreach Launch New Program to Improve Access to HIV and STI Testing Amid Surging Infection Rates

February 23, 2023

binx health to Present at the Upcoming BioCapital Europe 2023 Conference

December 12, 2022

binx health to Participate in William Blair’s Innovator Series: Life Science Tools and Diagnostics

November 10, 2022

binx health Announces Strategic Supply Agreement with Afaxys to Expand Sexual Health Test Access to Thousands of Clinics Nationally

November 1, 2022

Amid National Surge in Sexually Transmitted Infections binx health Announces Launch of Reagent Rental Program for Decentralized, Rapid, Point-of-Care Testing Platform for Chlamydia and Gonorrhea

October 4, 2022

Self-Collection Kits Provide Convenient Care for Sexually Transmitted Infections for Residents in All Alabama Counties

June 9, 2022

binx health CEO, Jeffrey Luber announced as an EY Entrepreneur Of The Year 2022® New England Award Winner

May 9, 2022

EY Announces Jeff Luber of binx health as an Entrepreneur Of The Year® 2022 New England Award Finalist

May 4, 2022

binx health and Wellfleet Partner to Broaden Equitable Access to HPV Screening through the binx everywhere care platform

April 5, 2022

binx health Appoints Life Sciences Veteran Jack Crowley as Chief Financial Officer

March 30, 2022

binx health Voted as Finalist in Medical Design Excellence Awards 2022

February 15, 2022

binx health and North Dakota Department of Public Health Partner to Combat the Spread of Sexually Transmitted Infections

February 8, 2022

Governments Turn to binx health to Expand Testing Efforts for COVID-19

December 14, 2021

binx health Selected as a Top Digital Health Startup that is Transforming the Future of Healthcare — Named to the 2021 CB Insights Digital Health 150 List

December 8, 2021

binx health and Student Health Insurer, Wellfleet, Expand Agreement in College Health for In-Dorm and At-Home Access to Testing for Sexually Transmitted Infections (STIs)